<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37587244</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-023-01661-3</ELocationID><Abstract><AbstractText>A significant proportion of patients after SARS-CoV-2 infection suffer from long-lasting symptoms. Although many different symptoms are described, the majority of patients complains about neuropsychological symptoms. Additionally, a subgroup of patients fulfills diagnostic criteria for ME/CFS. We analyzed a registry of all patients presenting in the out-patients clinic at a German university center. For patients with more than one visit, changes in reported symptoms from first to second visit were analyzed. A total of 1022 patients were included in the study, 411 of them had more than one visit. 95.5% of the patients reported a polysymptomatic disease. At the first visit 31.3% of the patients fulfilled ME/CFS criteria after a median time of 255&#xa0;days post infection and and at the second visit after a median of 402&#xa0;days, 19.4% still suffered from ME/CFS. Self-reported fatigue (83.7-72.7%) and concentration impairment (66.2-57.9%) decreased from first to second visit contrasting non-significant changes in the structured screening. A significant proportion of SARS-CoV-2 survivors presenting with ongoing symptoms present with ME/CFS. Although the proportion of subjective reported symptoms and their severity reduce over time, a significant proportion of patients suffer from long-lasting symptoms necessitating new therapeutic concepts.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reuken</LastName><ForeName>P A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-7696-475X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany. philipp.reuken@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besteher</LastName><ForeName>B</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7989-9298</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8546-7141</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holl</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katzer</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1136-0784</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmann-Pohl</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemh&#xf6;fer</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-6206-4064</Identifier><AffiliationInfo><Affiliation>Institute of Physical and Rehabilitation Medicine, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowka</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puta</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3936-4605</Identifier><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Sports Medicine and Health Promotion, Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Interdisciplinary Prevention of Diseases Related to Professional Activities, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei&#xdf;enborn</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0008-6378-1875</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stallmach</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6101-5244</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine IV (Gastroenterology, Hepatology and Infectious Diseases), Jena University Hospital/Friedrich-Schiller-University Jena, Am Klinikum 1, 07743, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care (CSCC), Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021 FGI 0060</GrantID><Agency>Th&#xfc;ringer Aufbaubank</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37587244</ArticleId><ArticleId IdType="doi">10.1007/s00406-023-01661-3</ArticleId><ArticleId IdType="pii">10.1007/s00406-023-01661-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV (2022) WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22(4):e102&#x2013;e107</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Giszas B, Trommer S, Sch&#xfc;&#xdf;ler N, Rodewald A, Besteher B, Bleidorn J et al (2022) Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID. Infection 51:365</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01886-9</ArticleId><ArticleId IdType="pubmed">35869353</ArticleId><ArticleId IdType="pmc">9307219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC et al (2021) Attributes and predictors of long COVID. Nat Med. Available from: http://www.nature.com/articles/s41591-021-01292-y</Citation></Reference><Reference><Citation>Nehme M, Vetter P, Chappuis F, Kaiser L, Guessous I, CoviCare Study team (2022) Prevalence of post-COVID condition 12 weeks after omicron infection compared to negative controls and association with vaccination status. Clin Infect Dis Off Publ Infect Dis Soc Am. 76:1567</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac947</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M et al (2022) A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 29(128):102&#x2013;111</Citation></Reference><Reference><Citation>DeVries A, Shambhu S, Sloop S, Overhage JM (2023) One-year adverse outcomes among US adults with post-COVID-19 condition vs those without COVID-19 in a large commercial insurance database. JAMA Health Forum 4(3):e230010</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.0010</ArticleId><ArticleId IdType="pubmed">36867420</ArticleId><ArticleId IdType="pmc">9984976</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11(1):16144</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId><ArticleId IdType="pmc">8352980</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A et al (2022) Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection 50(3):661&#x2013;669</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01733-3</ArticleId><ArticleId IdType="pubmed">34997542</ArticleId><ArticleId IdType="pmc">8741139</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y et al (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 101019</Citation></Reference><Reference><Citation>Kubota T, Kuroda N, Sone D (2023) Neuropsychiatric aspects of long COVID: a comprehensive review. Psychiatry Clin Neurosci 77(2):84&#x2013;93</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13508</ArticleId><ArticleId IdType="pubmed">36385449</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J (2021) COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis 8:204993612110093</Citation></Reference><Reference><Citation>Prins JB, van der Meer JW, Bleijenberg G (2006) Chronic fatigue syndrome. The Lancet 367(9507):346&#x2013;355</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68073-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira CR, Jason LA, Unutmaz D, Bateman L, Vernon SD (2022) Improvement of Long COVID symptoms over one year. Front Med 9:1065620</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1065620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo JA, Mart&#xed;nez-L&#xf3;pez JP, Carrillo-Lamp&#xf3;n SA, Ruiz-Ojeda D, Herrera-Ram&#xed;rez S, Amezcua-Guerra LM et al (2021) Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci 11(6):760</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId><ArticleId IdType="pmc">8227652</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR, Voit-Bak K, Donate T, Rodionov RN, Gainetdinov RR, Tselmin S et al (2022) Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol Psychiatry 27(1):34&#x2013;37</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01148-4</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection (2020) A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 20(8):e192&#x2013;7</Citation></Reference><Reference><Citation>Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5):1186&#x2013;1196</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0142(19990301)85:5&lt;1186::AID-CNCR24&gt;3.0.CO;2-N</ArticleId><ArticleId IdType="pubmed">10091805</ArticleId></ArticleIdList></Reference><Reference><Citation>Vries J, Michielsen H, Heck GL, Drent M (2004) Measuring fatigue in sarcoidosis: The Fatigue Assessment Scale (FAS). Br J Health Psychol 9(3):279&#x2013;291</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/1359107041557048</ArticleId><ArticleId IdType="pubmed">15296678</ArticleId></ArticleIdList></Reference><Reference><Citation>Radbruch L, Sabatowski R, Elsner F, Everts J, Mendoza T, Cleeland C (2003) Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage 25(5):449&#x2013;458</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0885-3924(03)00073-3</ArticleId><ArticleId IdType="pubmed">12727043</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS et al (2005) Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage 29(2):165&#x2013;172</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2004.04.013</ArticleId><ArticleId IdType="pubmed">15733808</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606&#x2013;613</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId><ArticleId IdType="pmc">1495268</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xc3;&#xa9;dirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment: MOCA: a brief screening tool for MCI. J Am Geriatr Soc. 53(4):695&#x2013;699</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler J, Holtzman C, Dudun C, Jason L (2018) A brief questionnaire to assess post-exertional malaise. Diagnostics 8(3):66</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId><ArticleId IdType="pmc">6165517</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S, Bloch W, Wagner H, Ellert C, Kr&#xfc;ger K, Vilser DC et al (2022) Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol. 3(1):iqac006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqac006</ArticleId><ArticleId IdType="pubmed">36846561</ArticleId><ArticleId IdType="pmc">9494493</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A et al (2021) Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 4:100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId><ArticleId IdType="pmc">8049853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN et al (2022) Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res 40:179&#x2013;196</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedberg P, Granath F, Bruchfeld J, Askling J, Sj&#xf6;holm D, Fored M et al (2023) Post COVID-19 condition diagnosis: a population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection. J Intern Med 293(2):246&#x2013;258</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13584</ArticleId><ArticleId IdType="pubmed">36478477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernas SN, Baldauf H, Real R, Sauter J, Markert J, Trost S et al (2023) Post-COVID-19 condition in the German working population: a cross-sectional study of 200,000 registered stem cell donors. J Intern Med 293(3):354&#x2013;370</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13587</ArticleId><ArticleId IdType="pubmed">36373223</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller K, Poppele I, Ottiger M, Zwingmann K, Berger I, Thomas A et al (2023) Impact of rehabilitation on physical and neuropsychological health of patients who acquired COVID-19 in the workplace. Int J Environ Res Public Health 20(2):1468</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021468</ArticleId><ArticleId IdType="pubmed">36674222</ArticleId><ArticleId IdType="pmc">9864141</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe9;cary S, De Groote W, Arienti C, Kiekens C, Boldrini P, Giuseppe Lazzarini S et al (2022) Scoping review of rehabilitation care models for post COVID-19 condition. Bull World Health Organ 100(11):676&#x2013;688</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.22.288105</ArticleId><ArticleId IdType="pubmed">36324552</ArticleId><ArticleId IdType="pmc">9589389</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H, Scheibenbogen C (2022) Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome. Inn Med Heidelb Ger 63(8):830&#x2013;839</Citation></Reference><Reference><Citation>Parker M, Sawant HB, Flannery T, Tarrant R, Shardha J, Bannister R et al (2023) Effect of using a structured pacing protocol on post&#x2010;exertional symptom exacerbation and health status in a longitudinal cohort with the post&#x2010;COVID&#x2010;19 syndrome. J Med Virol 95(1) https://doi.org/10.1002/jmv.28373</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21(3):133&#x2013;146</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Support for Rehabilitation Self-Management After COVID-19 Related Illness (WHO, 2021).</Citation></Reference><Reference><Citation>CDC. Treatment of ME/CFS|Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). CDC https://www.cdc.gov/me-cfs/treatment/index.html (2021).</Citation></Reference><Reference><Citation>Wright J, Astill S, Sivan M (2022) The relationship between physical activity and long COVID: a cross-sectional study. Int J Environ Res Public Health 19(9):5093</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId><ArticleId IdType="pmc">9105041</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Anglin K, Durstenfeld MS, Martin JN, Kelly JD, Hsue PY, et al. Effect of oral nirmatrelvir on Long COVID symptoms: a case series. In Review; 2022 May [cited 2023 Mar 11]. Available from: https://www.researchsquare.com/article/rs-1617822/v2</Citation></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L et al (2021) Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med 8:754667</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId></ArticleIdList></Reference><Reference><Citation>Giszas B, Reuken PA, Katzer K, Kiehntopf M, Schmerler D, Rummler S et al (2023) Use of immunoadsorption to treat patients with severe post-COVID syndrome. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther</Citation></Reference><Reference><Citation>Ceban F, Leber A, Jawad MY, Yu M, Lui LMW, Subramaniapillai M et al (2022) Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infect Dis 54(7):467&#x2013;477</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2022.2043560</ArticleId></ArticleIdList></Reference><Reference><Citation>Stallmach A, Katzer K, Besteher B, Finke K, Giszas B, Gremme Y et al (2022) Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study. Infection</Citation></Reference><Reference><Citation>Malone NC, Williams MM, Smith Fawzi MC, Bennet J, Hill C, Katz JN et al (2020) Mobile health clinics in the United States. Int J Equity Health 19(1):40</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-020-1135-7</ArticleId><ArticleId IdType="pubmed">32197637</ArticleId><ArticleId IdType="pmc">7085168</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebinger M, Siegerink B, Kunz A, Wendt M, Weber JE, Schwabauer E et al (2021) Association between dispatch of mobile stroke units and functional outcomes among patients with acute ischemic stroke in Berlin. JAMA 325(5):454</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.26345</ArticleId><ArticleId IdType="pubmed">33528537</ArticleId><ArticleId IdType="pmc">7856548</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>